{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:09:09Z","timestamp":1793048949608,"version":"4.5.0"},"reference-count":57,"publisher":"BMJ","issue":"7173","license":[{"start":{"date-parts":[[1998,12,12]],"date-time":"1998-12-12T00:00:00Z","timestamp":913420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"accepted":{"date-parts":[[1998,9,15]]},"published-print":{"date-parts":[[1998,12,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To determine whether intranasal corticosteroids are superior to oral H\n                    <jats:sub>1<\/jats:sub>\n                    receptor antagonists (antihistamines) in the treatment of allergic rhinitis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design:<\/jats:bold>\n                    Meta-analysis of randomised controlled trials comparing intranasal corticosteroids with oral antihistamines.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Setting:<\/jats:bold>\n                    Randomised controlled trials conducted worldwide and published between 1966 and 1997.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Subjects:<\/jats:bold>\n                    2267 subjects with allergic rhinitis in 16 randomised controlled trials.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Main outcome measures:<\/jats:bold>\n                    Nasal blockage, nasal discharge, sneezing, nasal itch, postnasal drip, nasal discomfort, total nasal symptoms, nasal resistance, and eye symptoms and global ratings. Outcomes measured on different scales were combined to determine pooled odds ratios (categorical outcomes) or standardised mean differences (continuous outcomes). Assessment of heterogeneity between studies, and subgroup analyses of eye symptoms, were undertaken.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Intranasal corticosteroids produced significantly greater relief than oral antihistamines of nasal blockage (standardised mean difference \u22120.63, 95% confidence interval \u22120.73 to \u22120.53), nasal discharge (\u22120.5, \u22120.6 to \u22120.4), sneezing (\u22120.49, \u22120.59 to \u22120.39), nasal itch (\u22120.38, \u22120.49 to \u22120.21), postnasal drip (\u22120.24, \u22120.42 to \u22120.06), and total nasal symptoms (\u22120.42, \u22120.53 to \u22120.32), and global ratings gave an odds ratio for deterioration of symptoms of 0.26 (0.08 to 0.8). There were no significant differences between treatments for nasal discomfort, nasal resistance, or eye symptoms. The effects on sneezing, total nasal symptoms, and eye symptoms were significantly heterogeneous between studies. Other combined outcomes were homogeneous between studies. Subgroup analysis of the outcome of eye symptoms suggested that the duration of assessment (averaged mean score over the study period versus mean score at end of study period) might have accounted for the heterogeneity.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The results of this systematic review, together with data on safety and cost effectiveness, support the use of intranasal corticosteroids over oral antihistamines as first line treatment for allergic rhinitis.\n                  <\/jats:p>","DOI":"10.1136\/bmj.317.7173.1624","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T19:56:05Z","timestamp":1319745365000},"page":"1624-1629","source":"Crossref","is-referenced-by-count":409,"title":["Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials"],"prefix":"10.1136","volume":"317","author":[{"given":"John M","family":"Weiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Puy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1998,12,12]]},"reference":[{"key":"2025122509081057000_317.7173.1624.1","first-page":"1","article-title":"International consensus report on the diagnosis and management of rhinitis.","volume":"49","year":"1994","journal-title":"Allergy"},{"key":"2025122509081057000_317.7173.1624.2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bmj.294.6567.279","article-title":"Prevalence of hay fever in England and Wales.","volume":"294","author":"Fleming","year":"1987","journal-title":"BMJ"},{"key":"2025122509081057000_317.7173.1624.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1989.tb02345.x"},{"key":"2025122509081057000_317.7173.1624.4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1753-6405.1995.tb00359.x","article-title":"Increase in the self-reported prevalence of asthma and hay fever in adults over the past generation.","volume":"19","author":"Hopper","year":"1995","journal-title":"Aust J Pub Health"},{"key":"2025122509081057000_317.7173.1624.5","unstructured":"Australian Bureau of Statistics, 1989-90 .National health survey. Asthma and other respiratory conditions Australia:Commonwealth Government Printer,1991."},{"key":"2025122509081057000_317.7173.1624.6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/00325481.1989.11700699","article-title":"Immediate and late effects of hay fever.","volume":"85","author":"Ziering","year":"1989","journal-title":"Postgrad Med"},{"key":"2025122509081057000_317.7173.1624.7","unstructured":"Calderon-Zapata MA Davies RJ .Treatment and management of allergic rhinitis. In: Kay AB , ed. Allergy and allergic diseases. Oxford:Blackwell,1997."},{"key":"2025122509081057000_317.7173.1624.8","first-page":"8","article-title":"Allergies for all seasons!","volume":"6","author":"Prenner","year":"1997","journal-title":"Allergy Asthma"},{"key":"2025122509081057000_317.7173.1624.9","unstructured":"Sackett D Oxman A , eds. The Cochrane Collaboration handbook. Oxford:Update Software,1996."},{"key":"2025122509081057000_317.7173.1624.10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1398-9995.1983.tb02361.x","article-title":"A comparative study of dexchlorpheniramine maleate sustained release tablets and budesonide nasal spray in seasonal allergic rhinitis.","volume":"38","author":"Munch","year":"1983","journal-title":"Allergy"},{"key":"2025122509081057000_317.7173.1624.11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1185\/03007998509109635","article-title":"A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis.","volume":"9","author":"Beswick","year":"1985","journal-title":"Curr Med Res Opin"},{"key":"2025122509081057000_317.7173.1624.12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2222.1986.tb00766.x","article-title":"Oral antihistamine or nasal steroid in hay fever; a double-blind double-dummy comparative study of once daily oral astemizole vs twice daily nasal beclomethasone dipropionate.","volume":"16","author":"Wood","year":"1986","journal-title":"Clin Allergy"},{"key":"2025122509081057000_317.7173.1624.13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1017\/S0022215100101768","article-title":"A comparison by rhinomanometry of beclomethasone and terfenadine in the treatment of seasonal rhinitis.","volume":"101","author":"Lancer","year":"1987","journal-title":"J Laryngol Otol"},{"key":"2025122509081057000_317.7173.1624.14","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90075-4"},{"key":"2025122509081057000_317.7173.1624.15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2222.1989.tb02437.x","article-title":"Double-blind cross-over trial comparing beclomethasone dipropionate and terfenadine in perennial rhinitis.","volume":"19","author":"Robinson","year":"1989","journal-title":"Clin Exp Allergy"},{"key":"2025122509081057000_317.7173.1624.16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1398-9995.1992.tb02060.x","article-title":"A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis.","volume":"47","author":"Bunnag","year":"1992","journal-title":"Allergy"},{"key":"2025122509081057000_317.7173.1624.17","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1365-2222.1994.tb03320.x","article-title":"A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen.","volume":"24","author":"Darnell","year":"1994","journal-title":"Clin Exp Allergy"},{"key":"2025122509081057000_317.7173.1624.18","first-page":"497","article-title":"Budesonide and terfenadine, separately and in combination, in the treatment of hay fever.","volume":"73","author":"Simpson","year":"1994","journal-title":"Ann Allergy"},{"key":"2025122509081057000_317.7173.1624.19","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1001\/archinte.1994.00420230086010","article-title":"Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis.","volume":"154","author":"Van Bavel","year":"1994","journal-title":"Arch Intern Med"},{"key":"2025122509081057000_317.7173.1624.20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0149-2918(95)80113-8","article-title":"Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis.","volume":"17","author":"Schoenwetter","year":"1995","journal-title":"Clin Ther"},{"key":"2025122509081057000_317.7173.1624.21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0091-6749(96)80151-5","article-title":"Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis.","volume":"97","author":"Bernstein","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"2025122509081057000_317.7173.1624.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)80065-0"},{"key":"2025122509081057000_317.7173.1624.23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2500\/105065896781794941","article-title":"Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given singly or in combination.","volume":"10","author":"Brooks","year":"1996","journal-title":"Am J Rhinol"},{"key":"2025122509081057000_317.7173.1624.24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1398-9995.1997.tb01027.x","article-title":"Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis.","volume":"52","author":"G\u00c3\u00a9hanno","year":"1997","journal-title":"Allergy"},{"key":"2025122509081057000_317.7173.1624.25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00044011-199713060-00001","article-title":"Intranasal fluticasone once daily compared with once daily cetirizine in the treatment of seasonal allergic rhinitis.","volume":"13","author":"Vervloet","year":"1997","journal-title":"Clin Drug Invest"},{"key":"2025122509081057000_317.7173.1624.26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2273.1991.tb00965.x","article-title":"Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis.","volume":"16","author":"Frolund","year":"1991","journal-title":"Clin Otolaryngol"},{"key":"2025122509081057000_317.7173.1624.27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0091-6749(96)70303-2","article-title":"Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis.","volume":"97","author":"Jordana","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"2025122509081057000_317.7173.1624.28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2222.1986.tb00767.x","article-title":"An open cross-over trial comparing two doses of astemizole and beclomethasone dipropionate in the treatment of perennial rhinitis.","volume":"16","author":"Sibbald","year":"1986","journal-title":"Clin Allergy"},{"key":"2025122509081057000_317.7173.1624.29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2273.1993.tb00805.x","article-title":"Dry powder inhalation of budesonide in allergic rhinitis.","volume":"18","author":"Andersson","year":"1993","journal-title":"Clin Otolaryngol"},{"key":"2025122509081057000_317.7173.1624.30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1742-1241.1984.tb07751.x","article-title":"Comparison of flunisolide nasal spray and terfenadine tablets in hay fever.","volume":"38","author":"Dickson","year":"1984","journal-title":"Br J Clin Pract"},{"key":"2025122509081057000_317.7173.1624.31","first-page":"35","article-title":"Treatment of seasonal allergic rhinitis with flunisolide and terfenadine.","volume":"14","author":"Backhouse","year":"1986","journal-title":"J Int Med Res"},{"key":"2025122509081057000_317.7173.1624.32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03258482","article-title":"Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis.","volume":"8","author":"Benincasa","year":"1994","journal-title":"Drug Invest"},{"key":"2025122509081057000_317.7173.1624.33","first-page":"340","article-title":"Adding loratadine to topical nasal steroid therapy improves moderately severe seasonal allergic rhinoconjunctivitis.","volume":"12","author":"Drouin","year":"1995","journal-title":"Adv Ther"},{"key":"2025122509081057000_317.7173.1624.34","first-page":"159","article-title":"The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.","volume":"31","author":"Davies","year":"1993","journal-title":"Rhinology"},{"key":"2025122509081057000_317.7173.1624.35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0091-6749(95)70313-6","article-title":"Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens.","volume":"95","author":"Pelucchi","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"2025122509081057000_317.7173.1624.36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2222.1976.tb01918.x","article-title":"Intranasal steroid aerosol in perennial rhinitis; comparison with an antihistamine compound.","volume":"6","author":"Harding","year":"1976","journal-title":"Clin Allergy"},{"key":"2025122509081057000_317.7173.1624.37","first-page":"109","article-title":"A clinical comparison of budesonide nasal aerosol, terfenadine and a combination therapy of budesonide and oxymetazoline in adult patients with perennial rhinitis.","volume":"8","author":"Lau","year":"1990","journal-title":"Asian Pac J Allergy Immunol"},{"key":"2025122509081057000_317.7173.1624.38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2222.1995.tb01003.x","article-title":"Oral antihistamine\/decongestant treatment compared with intranasal corticosteroids in seasonal allergic rhinitis.","volume":"25","author":"Negrini","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"2025122509081057000_317.7173.1624.39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1398-9995.1995.tb02586.x","article-title":"Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airways patency following allergen challenge.","volume":"50","author":"Hilberg","year":"1995","journal-title":"Allergy"},{"key":"2025122509081057000_317.7173.1624.40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1398-9995.1995.tb02736.x","article-title":"Nasal cytological changes following pharmacological intervention.","volume":"50","author":"Meltzer","year":"1995","journal-title":"Allergy"},{"key":"2025122509081057000_317.7173.1624.41","first-page":"244","article-title":"Comparison of an intranasal steroid (budesonide) with terfenadine in the treatment of ragweed-induced rhinoconjunctivitis.","volume":"85","author":"Ramsdale","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"2025122509081057000_317.7173.1624.42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0091-6749(91)91918-J","article-title":"Comparison of once daily treatment with an antihistamine (loratadine) and topical steroid (fluticasone propionate) during the ragweed pollen season.","volume":"87","author":"Ramsdale","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"2025122509081057000_317.7173.1624.43","first-page":"86","article-title":"Intranasal fluticasone propionate is more effective than astemizole for seasonal allergic rhinitis.","volume":"72","author":"Stricker","year":"1994","journal-title":"Ann Allergy"},{"key":"2025122509081057000_317.7173.1624.44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1081-1206(10)63315-7","article-title":"Changing strategies in the treatment of allergic rhinitis.","volume":"77","author":"Nathan","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025122509081057000_317.7173.1624.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70307-X"},{"key":"2025122509081057000_317.7173.1624.46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1081-1206(10)63320-0","article-title":"Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis.","volume":"77","author":"Munk","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025122509081057000_317.7173.1624.47","doi-asserted-by":"publisher","DOI":"10.1016\/0149-2918(95)80088-3"},{"key":"2025122509081057000_317.7173.1624.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1994.tb02724.x"},{"key":"2025122509081057000_317.7173.1624.49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/pai.1995.9.25","article-title":"The use of nasal corticosteroids in allergic rhinitis.","volume":"9","author":"Gawchick","year":"1995","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"2025122509081057000_317.7173.1624.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1988.tb02867.x"},{"key":"2025122509081057000_317.7173.1624.51","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/thx.52.5.476","article-title":"Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.","volume":"52","author":"Lipworth","year":"1997","journal-title":"Thorax"},{"key":"2025122509081057000_317.7173.1624.52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1993.tb00288.x"},{"key":"2025122509081057000_317.7173.1624.53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1398-9995.1994.tb00807.x","article-title":"Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children.","volume":"49","author":"Wolthers","year":"1994","journal-title":"Allergy"},{"key":"2025122509081057000_317.7173.1624.54","doi-asserted-by":"publisher","DOI":"10.1016\/0149-2918(95)80040-9"},{"key":"2025122509081057000_317.7173.1624.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302307"},{"key":"2025122509081057000_317.7173.1624.56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0149-2918(96)80014-2","article-title":"A comparison of costs and efficacy of intranasal fluticasone and terfenadine tablets for seasonal allergic rhinitis.","volume":"18","author":"Kozma","year":"1996","journal-title":"Clin Ther"},{"key":"2025122509081057000_317.7173.1624.57","first-page":"165","article-title":"Fluticasone propionate intranasal steroid: cost-effectiveness vs antihistamines.","volume":"93","author":"Berka","year":"1994","journal-title":"J Allergy Clin Immunol"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.317.7173.1624","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.317.7173.1624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T17:08:22Z","timestamp":1766682502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.317.7173.1624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12,12]]},"references-count":57,"journal-issue":{"issue":"7173","published-online":{"date-parts":[[1998,12,12]]},"published-print":{"date-parts":[[1998,12,12]]}},"alternative-id":["10.1136\/bmj.317.7173.1624"],"URL":"https:\/\/doi.org\/10.1136\/bmj.317.7173.1624","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12,12]]}}}